Migraine Drugs Market Expected to Reach $2,190 Million, Globally, by 2025
The market was valued at $1,713 million in 2017, and is expected to reach $2,190 million by 2025, growing at a CAGR of 3.1% from 2018 to 2025. North America is anticipated to be the highest revenue contributor throughout the forecast period.
The market was valued at $1,713 million in 2017, and is expected to reach $2,190 million by 2025, growing at a CAGR of 3.1% from 2018 to 2025. North America is anticipated to be the highest revenue contributor throughout the forecast period.
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
Opportunity Analysis and Industry Forecast, 2016-2023
Introductionof<br />
<strong>Migraine</strong> <strong>Drugs</strong> <strong>Market</strong><br />
The market was valued at $1,713 million in 2017, and is expected <strong>to</strong> reach <strong>$2</strong>,<strong>190</strong><br />
million <strong>by</strong> <strong>2025</strong>, growing at a CAGR of 3.1% from 2018 <strong>to</strong> <strong>2025</strong>. North America is<br />
anticipated <strong>to</strong> be the highest revenue contribu<strong>to</strong>r throughout the forecast period.<br />
<strong>Migraine</strong> is characterized <strong>by</strong> a recurrent throbbing headache, which affects only one<br />
side of the head. It is accompanied <strong>by</strong> vomiting, nausea, and even disturbed vision in<br />
some cases.<br />
Increase in prevalence of migraine, rapid rise in female population, and surge in<br />
awareness among patients for migraine treatment & prevention drive the growth of<br />
the global migraine drugs market. However, side effects of migraine drugs are<br />
expected <strong>to</strong> limit the market growth. Conversely, emerging new therapies/drugs for<br />
migraine treatment and growth opportunities in the emerging nations are expected <strong>to</strong><br />
present opportunities for the market growth during the forecast period.
Introductionof<br />
<strong>Migraine</strong> <strong>Drugs</strong> <strong>Market</strong><br />
Scope of the Report<br />
Key Benefits<br />
Key Audiences
Key Benefits<br />
• North America occupied two-fifths share of the global migraine<br />
drugs market.<br />
• Oral is anticipated <strong>to</strong> grow with the highest CAGR throughout the<br />
forecast period.<br />
• Europe is anticipated <strong>to</strong> occupy more than one-fourth market share<br />
of the global migraine drugs market <strong>by</strong> <strong>2025</strong>.<br />
• Asia-Pacific is anticipated <strong>to</strong> grow at the highest rate during the<br />
analysis period, followed <strong>by</strong> LAMEA.
Table of Content (TOC)<br />
Chapter: 1 Introduction<br />
Chapter: 2 Executive Summary<br />
Chapter: 3 <strong>Market</strong> Overview<br />
Chapter: 4: <strong>Migraine</strong> <strong>Drugs</strong> <strong>Market</strong>, By Type<br />
Chapter: 5: <strong>Migraine</strong> <strong>Drugs</strong> <strong>Market</strong>, By Route Of Administration<br />
Chapter: 6: <strong>Migraine</strong> <strong>Drugs</strong> <strong>Market</strong>, By Distribution Channel<br />
Chapter: 7: <strong>Migraine</strong> <strong>Drugs</strong> <strong>Market</strong>, By Region<br />
Chapter: 8: Company Profiles
Segments<br />
<strong>Migraine</strong> <strong>Drugs</strong> <strong>Market</strong>
Segments<br />
<strong>Migraine</strong> <strong>Drugs</strong> <strong>Market</strong>
Segments<br />
<strong>Migraine</strong> <strong>Drugs</strong> <strong>Market</strong>
Company Profiles<br />
<strong>Migraine</strong> <strong>Drugs</strong> <strong>Market</strong><br />
1. Abbott Labora<strong>to</strong>ries<br />
2. AbbVie Inc.<br />
3. Allergan Plc.<br />
4. AstraZeneca PLC<br />
5. Eisai Co., Ltd.<br />
6. Endo International Plc.
Thank You<br />
<strong>Migraine</strong> <strong>Drugs</strong> <strong>Market</strong><br />
ThankYou!<br />
For More Details<br />
Do Enquiry<br />
https://www.alliedmarketresearch.com/migraine-drugs-market<br />
Follow Us On
Change language